首页 / 院系成果 / 成果详情页

Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder 期刊论文

编号：

e0d1453e-9f56-400d-a4c1-279feb17a402
作者：

Wang, Zhifa#^[1,2]Cao, Yukun^[3];Yin, Qiang^[1];Han, Yuehu^[1];Wang, Yunya^[4];Sun, Guocheng^[1];Zhu, Hailong^[1];Xu, Ming(徐明)*^[5]Gu, Chunhu*^[1]
语种：

英文
期刊：

CARDIOVASCULAR THERAPEUTICS ISSN：1755-5914 2018 年 36 卷 6 期 ; DEC
收录：
关键词：

5'-monophosphate-activated protein kinase cardiopulmonary bypass glucose metabolic disorder glucose transporter-4
摘要：

Recent years, studies have demonstrated that hyperglycemia is one of the main manifestations after cardiac surgeries, which contributes to myocardial injuries and increases the chance of subsequent complications and mortality in such patients. However, strategies targeting at glucose metabolic disorder after cardiac surgeries to attenuate myocardial injuries are inadequately studied. In this study, a rat model of cardiopulmonary bypass (CPB) was applied to investigate the role of Adenosine 5'-monophosphate-activated protein kinase (AMPK) in modulating myocardial glucose metabolic-induced cardiac injuries after cardiac surgery. The results revealed that CPB elicited significant cardiac dysfunction, and pronouncedly elevated the markers of myocardial injuries including serum creatine kinase MB and cardiac troponin I. Additionally, blunted myocardial glucose uptake after CPB was associated with decreased membrane glucose transporter 4 (GLUT4) content. However, pretreatment of AMPK agonist 5-aminoimidazole-4-carboxamide1-beta-D-ribofuranoside (AICAR) at the beginning of CPB activated AMPK, enhanced phosphorylation of Akt substrate 160 (AS160), and increased myocardial membrane content of GLUT4. Meanwhile, improved myocardial glucose uptake and more importantly alleviated cardiac injury were also observed after CPB pretreated with AICAR. Moreover, the application of a mutant form of AS160 (AS160-4P) abolished the beneficial effect of AICAR, as evidenced by impaired cardiac glucose uptake, reduced myocardial membrane GLUT-4 translocation, increased cardiac injury markers, and deterioration of cardiac function after CPB. In conclusion, it was suggested in this study that preactivation of AMPK by AICAR improved myocardial glucose uptake by promoting AS160 dependent myocardial membrane GLUT-4 translocation, which ultimately provided a potent cardioprotective effect.
推荐引用方式
GB/T 7714：

Wang Zhifa,Cao Yukun,Yin Qiang, et al. Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder [J].CARDIOVASCULAR THERAPEUTICS,2018,36(6).
APA：

Wang Zhifa,Cao Yukun,Yin Qiang,Han Yuehu,&Gu Chunhu.(2018).Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder .CARDIOVASCULAR THERAPEUTICS,36(6).
MLA：

Wang Zhifa, et al. "Activation of AMPK alleviates cardiopulmonary bypass-induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder" .CARDIOVASCULAR THERAPEUTICS 36,6(2018).
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：40  下载次数：0

分享到：

浏览次数：40

下载次数：0

打印次数：0